Your session is about to expire
← Back to Search
Buprenorphine + IDC for Post-Traumatic Stress Disorder
Study Summary
This trial will test whether CPT-C, a standard psychotherapy, is more effective in treating PTSD than a control group among Veterans with PTSD and comorbid OUD who are maintained on buprenorphine.
- Post Traumatic Stress Disorder
- Opioid Use Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are participants being recruited for this experiment at this time?
"That is accurate. According to clinicaltrials.gov, this trial was originally posted on October 1st 2018 and is still recruiting patients. The study needs around 160 participants from 2 locations."
Might I be able to help with this research project?
"Eligible patients must have the disease and be of ages 18-65. There are approximately 160 spots available in the study."
Has the Food and Drug Administration given their blessing to Buprenorphine + CPT-C?
"Buprenorphine + CPT-C is in Phase 2 of clinical trials, meaning that while there is evidence suggesting it is safe, none of the data collected thus far has been promising enough to suggest efficacy."
Are there any previous cases of research on Buprenorphine + CPT-C?
"At the moment, 44 ongoing clinical trials are researching Buprenorphine + CPT-C. Out of these, 12 have reached Phase 3. Most of the research surrounding Buprenorphine + CPT-C is based in Durham, North carolina; however, there are 228 total locations conducting trials for this medication."
How many people are signed up to participate in this research project?
"Yes, as specified on clinicaltrials.gov, this trial is currently looking for 160 patients from 2 locations. The first posting was on October 1st, 2018 and the most recent update was on April 6th, 2022."
Is this study open to people who are over 25 years old?
"According to the inclusion criteria, patients who are eligible for this trial fall between 18-65 years of age. There are currently 301 clinical trials underway for individuals below 18 and 923 for those above 65."
Share this study with friends
Copy Link
Messenger